Prothya Logo

Prothya Biosolutions, formed in 2021 through the merger of Plasma Industries Belgium and Sanquin Plasma Products, brings over 60 years of experience in plasma collection and medicinal product manufacturing. They focus on stable plasma derivatives and aim to harness the potential of the human plasma proteome for disease treatment. Their organization processes around 3 million liters of plasma annually for international partners.